Brief: Julphar Enters Into A Subscription Agreement With Quantum Genomics
April 27 (Reuters) - GULF PHARMACEUTICAL INDUSTRIES PSC
JULPHAR.AD :
* ENTERS INTO A SUBSCRIPTION AGREEMENT WITH QUANTUM GENOMICS
* TO SUBSCRIBE NEW ORDINARY SHARES OF QUANTUM GENOMICS SHARE
CAPITAL FOR AN AGGREGATE SUBSCRIPTION PRICE OF USD 2 MILLION
Source text for Eikon: ID:nADXE22585
Further company coverage: JULPHAR.AD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study